Serbia

Serbia is one of the fast growing emerging clinical trials markets in Europe. It has many advantages for conducting clinical studies:
  • Clinical trial approval time takes up to 2 months.
  • Rapid enrollment.
  • Significant economic advantages.
  • High site productivity.
  • Significant clinical trial potential in major therapeutic areas.
  • Advanced clinical infrastructure.
Smooth Drug Development provides CRO services in Serbia.